As expectations around the US-India trade deal strengthen and the Trump administration on Tuesday reiterated its warning of a 10 percent tariff on BRIC nations, including India, the market is showing some nervousness.

Trump also added that the deadline on the tariff implemenation will not be prolonged beyond August 1.

In its stance on India, considering India is a major trading partner, Trump pointed out that there shall be no relaxation made even for India. Trump explicitly stated that India's membership in BRICS means it would be subject to the same additional 10% tariffs. However, the markets after a lacklustre trade in the morning session managed to end in the green with the bluechip Nifty50 index topping 25,500 levels.

Zee Business Managing Editor Anil Singhvi said, " on the trade deal front with the US, there are two positive news for India:

Nonetheless, for the BRICS nations, President warned of a likely 10 per cent tariffs. Experts held that for India if the tariffs go below 10 per cent, it will likely induce a relief rally. 

Singhvi noted that the Trump administration's continuous remarks increased the chances of an India-US trade deal, which led to fad-end buying on D-Street in the previous session.Further, the expert added that the markets will attempt to move in the higher band of 25,600-25,670.

So, for now the possible chances of breaking below the lower levels have declined.

Also, he said that markets may be volatile for some time now ahead of the deal and then post the deal.

Amid the trade deal, the stop loss recommended by the market guru for Nifty and Bank Nifty is at 25,300 and 56,500, respectively. So, for mitigating the higher volatility, the expert advises to trade in low quantities, while keeping strict stop losses.

And for now, pharma scrips that did not perform well look good for buying now.